Respiri Limited (RSH.AX)
AUD 0.04
(2.86%)
AUD 0.04
(2.86%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -7.12 Million AUD | -23.44% |
| 2023 | -5.77 Million AUD | 12.82% |
| 2022 | -6.62 Million AUD | 40.0% |
| 2021 | -11.04 Million AUD | -52.05% |
| 2020 | -7.26 Million AUD | 14.32% |
| 2019 | -8.47 Million AUD | -164.23% |
| 2018 | -3.2 Million AUD | -27.17% |
| 2017 | -2.52 Million AUD | 37.12% |
| 2016 | -4.01 Million AUD | 26.6% |
| 2015 | -5.46 Million AUD | 47.0% |
| 2014 | -10.3 Million AUD | -84.65% |
| 2013 | -5.58 Million AUD | 0.03% |
| 2012 | -5.58 Million AUD | 16.36% |
| 2011 | -6.67 Million AUD | -12.42% |
| 2010 | -5.93 Million AUD | 11.36% |
| 2009 | -6.7 Million AUD | 42.62% |
| 2008 | -11.67 Million AUD | -127.77% |
| 2007 | -5.12 Million AUD | -317.78% |
| 2006 | -1.22 Million AUD | -69.46% |
| 2005 | -724.19 Thousand AUD | -221.23% |
| 2004 | -225.44 Thousand AUD | 94.75% |
| 2003 | -4.29 Million AUD | 63.81% |
| 2002 | -11.86 Million AUD | -36.43% |
| 2001 | -8.69 Million AUD | -42.66% |
| 2000 | -6.09 Million AUD | -568.24% |
| 1999 | -912.09 Thousand AUD | -193.25% |
| 1998 | -311.03 Thousand AUD | -221.46% |
| 1997 | 256.08 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -3.18 Million AUD | 0.0% |
| 2024 FY | -7.43 Million AUD | -28.76% |
| 2024 Q4 | -3.94 Million AUD | 0.0% |
| 2023 Q2 | -2.57 Million AUD | 0.0% |
| 2023 Q4 | -3.19 Million AUD | 0.0% |
| 2023 FY | -5.77 Million AUD | 12.82% |
| 2022 Q2 | -3.04 Million AUD | 0.0% |
| 2022 FY | -6.62 Million AUD | 40.0% |
| 2022 Q4 | -3.57 Million AUD | 0.0% |
| 2021 Q4 | -4.65 Million AUD | 0.0% |
| 2021 Q2 | -6.38 Million AUD | 0.0% |
| 2021 FY | -11.04 Million AUD | -52.05% |
| 2020 FY | -7.26 Million AUD | 14.32% |
| 2020 Q2 | -1.42 Million AUD | 0.0% |
| 2020 Q4 | -5.83 Million AUD | 0.0% |
| 2019 FY | -8.47 Million AUD | -164.23% |
| 2019 Q4 | -5.37 Million AUD | 0.0% |
| 2019 Q2 | -3.1 Million AUD | 0.0% |
| 2018 FY | -3.2 Million AUD | -27.17% |
| 2018 Q2 | -782.9 Thousand AUD | 0.0% |
| 2018 Q4 | -2.42 Million AUD | 0.0% |
| 2017 Q2 | -1.86 Million AUD | 0.0% |
| 2017 Q4 | -658.1 Thousand AUD | 0.0% |
| 2017 FY | -2.52 Million AUD | 37.12% |
| 2016 Q4 | -1.39 Million AUD | 0.0% |
| 2016 Q2 | -2.61 Million AUD | 0.0% |
| 2016 FY | -4.01 Million AUD | 26.6% |
| 2015 Q4 | -2.42 Million AUD | 0.0% |
| 2015 FY | -5.46 Million AUD | 47.0% |
| 2015 Q2 | -3.04 Million AUD | 0.0% |
| 2014 Q2 | -7.12 Million AUD | 0.0% |
| 2014 FY | -10.3 Million AUD | -84.65% |
| 2014 Q4 | -3.18 Million AUD | 0.0% |
| 2013 Q2 | -2.89 Million AUD | -107.49% |
| 2013 Q1 | -1.39 Million AUD | 0.0% |
| 2013 FY | -5.58 Million AUD | 0.03% |
| 2013 Q4 | -2.68 Million AUD | -92.35% |
| 2013 Q3 | -1.39 Million AUD | 51.84% |
| 2012 Q4 | - AUD | 100.0% |
| 2012 FY | -5.58 Million AUD | 16.36% |
| 2012 Q2 | -1.39 Million AUD | 16.36% |
| 2012 Q3 | -1.39 Million AUD | 0.0% |
| 2012 Q1 | -1.66 Million AUD | 0.0% |
| 2011 Q2 | -1.66 Million AUD | -12.42% |
| 2011 Q1 | -1.48 Million AUD | 0.0% |
| 2011 FY | -6.67 Million AUD | -12.42% |
| 2011 Q4 | - AUD | 100.0% |
| 2011 Q3 | -1.66 Million AUD | 0.0% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 Q3 | -1.48 Million AUD | 0.0% |
| 2010 Q1 | -1.67 Million AUD | 0.0% |
| 2010 Q2 | -1.48 Million AUD | 11.36% |
| 2010 FY | -5.93 Million AUD | 11.36% |
| 2009 Q3 | -1.67 Million AUD | 0.0% |
| 2009 Q2 | -1.67 Million AUD | 42.62% |
| 2009 Q4 | - AUD | 100.0% |
| 2009 FY | -6.7 Million AUD | 42.62% |
| 2009 Q1 | -2.91 Million AUD | 0.0% |
| 2008 Q2 | -2.91 Million AUD | -127.89% |
| 2008 Q4 | - AUD | 100.0% |
| 2008 FY | -11.67 Million AUD | -127.77% |
| 2008 Q1 | -1.28 Million AUD | 0.0% |
| 2008 Q3 | -2.91 Million AUD | 0.0% |
| 2007 Q1 | -297.83 Thousand AUD | 0.0% |
| 2007 FY | -5.12 Million AUD | -317.78% |
| 2007 Q4 | - AUD | 100.0% |
| 2007 Q3 | -1.28 Million AUD | 0.0% |
| 2007 Q2 | -1.28 Million AUD | -330.14% |
| 2006 Q3 | -297.83 Thousand AUD | 0.0% |
| 2006 Q2 | -297.83 Thousand AUD | -64.51% |
| 2006 FY | -1.22 Million AUD | -69.46% |
| 2006 Q4 | - AUD | 100.0% |
| 2006 Q1 | -181.04 Thousand AUD | 0.0% |
| 2005 FY | -724.19 Thousand AUD | -221.23% |
| 2005 Q3 | -181.04 Thousand AUD | 0.0% |
| 2005 Q2 | -181.04 Thousand AUD | -221.23% |
| 2005 Q1 | -56.36 Thousand AUD | 0.0% |
| 2005 Q4 | - AUD | 100.0% |
| 2004 Q1 | -1.07 Million AUD | 0.0% |
| 2004 Q2 | -56.36 Thousand AUD | 94.75% |
| 2004 Q3 | -56.36 Thousand AUD | 0.0% |
| 2004 Q4 | - AUD | 100.0% |
| 2004 FY | -225.44 Thousand AUD | 94.75% |
| 2003 Q4 | - AUD | 100.0% |
| 2003 Q1 | -2.96 Million AUD | 0.0% |
| 2003 Q2 | -1.07 Million AUD | 63.81% |
| 2003 Q3 | -1.07 Million AUD | 0.0% |
| 2003 FY | -4.29 Million AUD | 63.81% |
| 2002 Q3 | -2.96 Million AUD | 0.0% |
| 2002 Q1 | -2.17 Million AUD | 0.0% |
| 2002 Q4 | - AUD | 100.0% |
| 2002 Q2 | -2.96 Million AUD | -36.43% |
| 2002 FY | -11.86 Million AUD | -36.43% |
| 2001 Q1 | -1.52 Million AUD | 0.0% |
| 2001 Q4 | - AUD | 100.0% |
| 2001 Q3 | -2.17 Million AUD | 0.0% |
| 2001 Q2 | -2.17 Million AUD | -42.66% |
| 2001 FY | -8.69 Million AUD | -42.66% |
| 2000 Q3 | -1.52 Million AUD | 0.0% |
| 2000 Q1 | -228.02 Thousand AUD | 0.0% |
| 2000 FY | -6.09 Million AUD | -568.24% |
| 2000 Q4 | -1.52 Million AUD | 0.0% |
| 2000 Q2 | -1.52 Million AUD | -568.22% |
| 1999 FY | -912.09 Thousand AUD | -193.25% |
| 1999 Q3 | -228.02 Thousand AUD | 0.0% |
| 1999 Q4 | -228.02 Thousand AUD | 0.0% |
| 1999 Q2 | -228.02 Thousand AUD | -193.25% |
| 1999 Q1 | -77.75 Thousand AUD | 0.0% |
| 1998 Q4 | -77.75 Thousand AUD | 0.0% |
| 1998 Q3 | -77.75 Thousand AUD | 0.0% |
| 1998 FY | -311.03 Thousand AUD | -221.46% |
| 1998 Q1 | 64.02 Thousand AUD | 0.0% |
| 1998 Q2 | -77.75 Thousand AUD | -221.46% |
| 1997 FY | 256.08 Thousand AUD | 0.0% |
| 1997 Q4 | 64.02 Thousand AUD | 0.0% |
| 1997 Q2 | 64.02 Thousand AUD | 0.0% |
| 1997 Q3 | 64.02 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 80.185% |
| Adherium Limited | -10.22 Million AUD | 30.271% |
| Aroa Biosurgery Limited | -9.74 Million AUD | 26.867% |
| Atomo Diagnostics Limited | -6.84 Million AUD | -4.11% |
| Anteris Technologies Ltd | -67.33 Million AUD | 89.412% |
| Control Bionics Limited | -5.91 Million AUD | -20.553% |
| CardieX Limited | -6.76 Million AUD | -5.379% |
| Compumedics Limited | -338 Thousand AUD | -2009.245% |
| Cochlear Limited | 356.8 Million AUD | 101.998% |
| CleanSpace Holdings Limited | -3.12 Million AUD | -127.98% |
| Cyclopharm Limited | -4.7 Million AUD | -51.66% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | -161.182% |
| Nova Eye Medical Limited | -8.79 Million AUD | 18.894% |
| HeraMED Limited | -6.78 Million AUD | -5.094% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 68.491% |
| ImpediMed Limited | -19.79 Million AUD | 63.976% |
| InhaleRx Limited | -1.44 Million AUD | -393.965% |
| LBT Innovations Limited | -3.74 Million AUD | -90.622% |
| Micro-X Limited | -9.76 Million AUD | 26.992% |
| Neurotech International Limited | -5.06 Million AUD | -40.637% |
| OncoSil Medical Limited | -11.91 Million AUD | 40.159% |
| PolyNovo Limited | 5.26 Million AUD | 235.511% |
| SomnoMed Limited | -12.24 Million AUD | 41.763% |
| Universal Biosensors, Inc. | -6.74 Million AUD | -5.751% |
| Uscom Limited | -2.07 Million AUD | -243.62% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | -40.802% |